Infusion pump companies are perpetuating misconceptions.
The center will start phasing in efficiencies on March 18.
The resignation will be effective in about a month, according to reports.
The regulation is bringing digital enablement to the forefront, requiring electronic instructions for use.
According to the FDA, more than 90% of products sterilized at the facility are medical devices.
Learn about the new subclass for Class I reusable devices under MDR and the necessary steps to ensure compliance.
The new pump allows patients to customize their diabetes management.
If you’re looking to market your medical device, there are many tasks to complete.
The agency’s intent is to decrease regulatory burden while promoting patient access to products.
The device approvals address critical patient need.